This inventor holds 1 USPTO granted patent. Top assignee: Amersham International Plc. Active years: 1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999
Title: The Innovative Contributions of Susan Jane Dale
Introduction
Susan Jane Dale is a notable inventor based in Harrow, GB. She has made significant contributions to the field of biotechnology, particularly through her innovative patent related to drug screening technologies. Her work exemplifies the intersection of scientific research and practical applications in medicine.
Latest Patents
Susan holds a patent for a "Reverse two-hybrid system employing post-translation signal modulation." This invention pertains to modified two-hybrid systems, specifically a reverse two-hybrid system that utilizes a reporter gene encoding a modifying agent, such as an enzyme. The system produces a detectable signal when there is an inhibition of binding between the two hybrid proteins, making it particularly useful for drug screening. This patent highlights her expertise in developing advanced methodologies for biological research.
Career Highlights
Throughout her career, Susan has been associated with Amersham International Plc, where she has contributed to various projects that bridge the gap between research and practical applications. Her work has not only advanced scientific understanding but has also paved the way for new drug discovery processes.
Collaborations
Susan has collaborated with notable colleagues, including Douglas Hurd and Rachel Alison Fallon. These partnerships have enriched her research and expanded the impact of her inventions in the scientific community.
Conclusion
Susan Jane Dale's innovative work in biotechnology, particularly her patented reverse two-hybrid system, showcases her significant contributions to drug screening technologies. Her career reflects a commitment to advancing scientific research and its applications in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
